NASDAQ$TEM

Tempus AI Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

Tempus AI reported Q1 2026 total net revenue of $348.1M and a net loss of $125.9M, or $0.71 diluted EPS.

For the quarter ended March 31, 2026, Tempus AI generated total net revenue of $348.1 million (diagnostics $261.1 million, data and applications $87.0 million), up from $255.7 million. Net loss widened to $125.9 million ($0.71 per share) from $68.0 million as operating expenses rose with Ambry integration and R&D scale.

  • Total net revenue $348.1M (+36% YoY).
  • Diagnostics revenue $261.1M; data/applications $87.0M.
  • Net loss $125.9M; diluted EPS $(0.71).
  • Operating loss $84.7M on higher SG&A and R&D.

Headline financials

Total Revenue

$348M

Previous: $256M+36.1%
EPS (adj)

-$0.71

Previous: -$0.40-77.5%
Capital Expenditures

-$8.2M

Previous: -$2.07M-295.5%
Free Cash Flow

-$81.5M

Previous: -$70.1M-16.2%
Net Income

-$126M

Previous: -$68M-85.1%
Operating Income

-$84.7M

Previous: -$68.7M-23.3%
Gross Profit

-$3.35M

Previous: -$333K-904.8%
Cash & Equivalents

$521M

Previous: $152M+243.8%
Total Assets

$2.14B

Previous: $1.54B+38.4%

Revenue & EPS history

Tempus AI Inc · Revenue · Quarterly

$348M

Q1 2026+36.1%vs Q1 2025
Beat estimate in 6 of 8 quarters(75%)
ActualEstimate

Revenue by segment

Tempus AI Inc · $146M total across 2 segments · Q1 2024

  • Diagnostics
    $103M
  • Data and Applications
    $43.3M

Forward guidance

Growth company; outlook tied to testing volume, data licensing, and path to profitability rather than near-term EPS guidance in the 10-Q.

Tailwinds

  • Double-digit revenue growth across diagnostics and data.
  • Large addressable market in precision medicine and AI data.

Headwinds

  • Losses widened with acquisition and growth investments.
  • Reimbursement and regulatory paths remain critical.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 10 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

-0.5%

Avg return

Earnings day

+10.9%

Avg return

5 days after

+12.9%

Avg return

30 days after

50%

5 / 10 earnings

Positive

+12.6%

Q1 2025

Best reaction

-15.0%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.1%-10.7%-7.2%
Q4 2025+3.6%-8.0%-26.5%
Q3 2025-2.7%-15.0%-9.3%
Q2 2025+3.4%+18.5%+35.5%
Q1 2025+12.6%+20.1%+18.9%
Q4 2024-15.0%-19.2%-25.3%
Q3 2024-3.4%+60.2%+25.9%
Q3 2023-3.4%+60.2%+25.9%
Q2 2024+1.6%+1.4%+45.6%
Q2 2023+1.6%+1.4%+45.6%
Q1 2024
Q1 2023
Q4 2022
Q3 2021
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro